IP Library Granted Patent US 9,931,434
Granted Patent B2
US 9,931,434 · App. 14/357,443 · Granted Apr 3, 2018

Injectable silk fibroin particles and uses thereof

Inventors: Evangelia Bellas (Somerville, MA); Kacey Marra (Canonsburg, PA); J. Peter Rubin (Pittsburgh, PA); David L. Kaplan (Concord, MA); James J. Yoo (Winston-Salem, NC)
Assignees: Trustees of Tufts College; University of Pittsburgh of the Commonwealth System of Higher Education; Wake Forest University Health Sciences
A61L27/227A61L27/3604A61L27/3834A61L27/48A61L27/54A61L27/56A61L27/58A61L2400/06A61L2430/34Y10T428/2982
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,931,434
App. No.
14/357,443
Granted
Apr 3, 2018
Kind
B2
Abstract

The inventions provided herein relate to compositions, methods, delivery devices and kits for repairing or augmenting a tissue in a subject. The compositions described herein are injectable such that they can be placed in a tissue to be treated with a minimally-invasive procedure (e.g., by injection) and/or be molded flexibly into a tissue void of any shape and/or size. In some embodiments, the composition described herein comprises a plurality of silk fibroin particles, which can retain their original volume within the tissue for a period of time. The compositions can be used as a filler to replace a tissue void, e.g., for tissue repair and/or augmentation, or as a scaffold to support tissue regeneration and/or reconstruction. In some embodiments, the compositions described herein can be used for soft tissue repair or augmentation.

Claims (19)

1. An injectable composition comprising:

porous silk fibroin particles in an injectable format, wherein the porous silk fibroin particles have a porosity of at least 70, and wherein the silk fibroin constitutes at least 30% of the total composition; and

wherein the injectable composition further comprises a biological fluid comprising lipoaspirate in a volume ratio between 3:19 to 6:19 silk fibroin to lipoaspirate,

wherein the processed lipoaspirate has not been subjected to preferential expansion of one cell type over another.

2. The injectable composition of claim 1 , wherein the tissue site is a soft tissue site.

3. The injectable composition of claim 1 , wherein the tissue site is a hard tissue site.

4. The injectable composition of claim 3 , wherein the hard tissue site is bone tissue.

5. The injectable composition of claim 1 , wherein the porous silk fibroin particles have a size of about 500 μm to about 5,000 μm.

6. The injectable composition of claim 2 , wherein the porous silk fibroin particles retain at least about 50% of their original volume after being placed into the soft tissue site in the subject for the period of time.

7. The injectable composition of claim 1 , wherein the period of time is at least about 3 months.

8. The injectable composition of claim 1 , wherein the period of time is at least about 6 months.

9. The injectable composition of claim 1 , wherein the porous silk fibroin particles have a porosity of at least about 90.

10. A delivery device comprising the injectable composition of claim 1 .

11. The delivery device of claim 10 , further comprising an injection carrier.

12. A method of repairing or augmenting a tissue site in a subject comprising administering the injectable composition of claim 1 .

13. The composition of claim 1 , further comprising bone-marrow aspirate.

14. The composition of claim 13 , wherein the bone-marrow aspirate is in a volume ratio of about 1:38 to 12:19 silk fibroin to biological fluid or concentrate.

15. The composition of claim 1 , wherein the lipoaspirate comprises one or more cells.

16. The composition of claim 15 , wherein the one or more cells is not cultured prior to administration.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jan 10, 2017
From: TUFTS UNIVERSITY BOSTON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041311/0120 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2014
From: BELLAS, EVANGELIA; KAPLAN, DAVID L.
To: TRUSTEES OF TUFTS COLLEGE
Reel/Frame 034206/0515 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2014
From: MARRA, KACEY; RUBIN, J. PETER
To: UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
Reel/Frame 034206/0533 →
Continuity (2)
Provisional Application 61557603 · Nov 9, 2011
Related Publication 20140308362A1 · Oct 16, 2014